Retinoblastoma-binding protein 2 (RBP2) is frequently expressed in neuroendocrine tumors and promotes the neoplastic phenotype

Neuroendocrine tumors (NETs), which can have survival rates as low as 4%, currently have limited therapeutic interventions available highlighting the dire need for the identification of novel biological targets for use as new potential drug targets. One such potential target is retinoblastoma-bindin...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggi, E C, Trillo-Tinoco, J, Struckhoff, A P, Vijayaraghavan, J, Del Valle, L, Crabtree, J S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007832/
https://www.ncbi.nlm.nih.gov/pubmed/27548814
http://dx.doi.org/10.1038/oncsis.2016.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007832/
https://www.ncbi.nlm.nih.gov/pubmed/27548814
http://dx.doi.org/10.1038/oncsis.2016.58

Ejemplares similares